Dierckx, Rudi
Herrmann, Ken
Hustinx, Roland
Lassmann, Michael
Wadsak, Wolfgang
Kunikowska, Jolanta http://orcid.org/0000-0002-7434-6720
Article History
First Online: 17 October 2022
Change Date: 14 November 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00259-022-06037-8
Declarations
:
: This manuscript does not contain proprietary research involving neither humans nor animals.
: This manuscript does not contain proprietary human data, accordingly an informed consent is not applicable.
: This editorial falls outside of the scope of ethical concerns regarding experimentation with humans or animals.
: All authors gave their written consent for publication.
: KH reports personal fees from Bayer, personal fees and other from Sofie Biosciences, personal fees from SIRTEX, non-financial support from ABX, personal fees from Adacap, personal fees from Curium, personal fees from Endocyte, grants and personal fees from BTG, personal fees from IPSEN, personal fees from Siemens Healthineers, personal fees from GE Healthcare, personal fees from Amgen, personal fees from Novartis, personal fees from ymabs, personal fees from Aktis Oncology, personal fees from Theragnostics, personal fees from Pharma15, personal fees from Debiopharm, personal fees from AstraZeneca, personal fees from Janssen, outside the submitted work.ML has received research grants by IPSEN Pharma and Nordic Nanovector.WW has received research grants from ITM S.E., Scintomics, EZAG, Novo Nordisk (all institutional fees), consultancy fees from GE Healthcare (personal fees) and is a part-time employee of CBmed GmbH, Graz, Austria, and a founder and co-owner of MINUTE medical GmbH, Vienna, Austria.JK reports consulting fees from Telix; participation on a Data Safety Monitoring Board and Advisory Board from Novartis (personal fees), unrestricted grant from Janssen.The remaining authors have no relevant conflict of interest to declare with regard to this comment.
Free to read: This content has been made available to all.